Carlos Guida Medical is categorized under Family Practice Doctors in Miami, FL and active since 1997.
Carlos Guida Medical was established in 1997, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Humberto Guida, Office Manager at the company’s single location by writing to 351 Nw 42nd Avenue # 409, Miami, Florida FL 33126 or by phoning (305) 643-6500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Carlos Guida Medical |
| Contact Person: | Humberto Guida, Office Manager |
| Address: | 351 Nw 42nd Avenue # 409, Miami, Florida 33126 |
| Phone Number: | (305) 643-6500 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Carlos Guida Medical was started in 1997 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Humberto Guida, Office Manager for inquiries that concern Carlos Guida Medical by calling the company number (305) 643-6500, as your correspondence is most welcome. Additionally, the physical location of the single location of Carlos Guida Medical can be found at the coordinates 25.77556,-80.26373 as well as the street address 351 Nw 42nd Avenue # 409 in Miami, Florida 33126.
For its online presence, you may visit Carlos Guida Medical’s website at and engage with its social media outlets through on Twitter and on Facebook.